Mesoblast Ltd (MESO) stock
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
$13.27+0.17 (+1.30%)
Close on Nov 13, 2026Market cap $1.72BP/E –Yield –
Mesoblast enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Mesoblast's enterprise value was $1.79B on Nov 11, 2026, against $2.10B a year earlier. Over the last 5 years it ranged from $180.28M to $2.19B, with a median of $631.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.79B | -18.2% |
| 2025 | Dec 31, 2025 | $2.19B | +8.6% |
| 2024 | Dec 31, 2024 | $2.02B | +841.2% |
| 2023 | Dec 29, 2023 | $214.50M | -49.4% |
| 2022 | Dec 30, 2022 | $424.08M | -32.8% |
| 2021 | Dec 31, 2021 | $631.06M | -33.6% |
| 2020 | Dec 31, 2020 | $951.08M | +18.7% |
| 2019 | Dec 31, 2019 | $801.13M | +94.1% |
| 2018 | Dec 31, 2018 | $412.68M | -1.8% |
| 2017 | Dec 29, 2017 | $420.32M | +36.1% |
| 2016 | Dec 30, 2016 | $308.77M | – |
See a number that looks wrong?